The role of pharmacogenetics in cancer therapeutics

N/ACitations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The variability in treatment responses and narrow therapeutic index of anticancer drugs are some of the key challenges oncologists face. The knowledge of pharmacogenetics can potentially aid in the discovery, development and ultimately individualization of anticancer drugs. The identification of genetic variations that predict for drug response is the first step towards the translation of pharmacogenetics into clinical practice. This review provides an update on the results of studies assessing the effects of germline polymorphisms and somatic mutations on therapeutic outcomes and highlights the potential applications and future challenges in pharmacogenetic research pertaining to cancer therapeutics. © 2006 The Authors.

Cite

CITATION STYLE

APA

Yong, W. P., Innocenti, F., & Ratain, M. J. (2006, July). The role of pharmacogenetics in cancer therapeutics. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2006.02591.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free